VSee Health, Inc. (VSEE)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • PINK
Market Cap: $1.28M
Last updated: Nov 13, 2026 at 4:00 PM ET
VSee Health, Inc. (VSEE) Financials: Revenue, Profit and Cash Flow
VSee Health reported revenue of $14.62M for the fiscal year ended Dec 31, 2025, up 40.3% from the year before. That year, net income was -$14.71M with a net margin of -100.6%, operating cash flow was -$3.45M and free cash flow was -$3.48M. The quarter ended Jun 30, 2026 had revenue of $1.56M and net income of $847.27K.
Revenue and Margins
The operating margin was -65.6% in the fiscal year ended Dec 2025, the lowest of the 4 years shown with an operating margin. Over the 5 years to Dec 2025, revenue grew from $6.80M, a compound annual rate of 16.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $14.62M | +40.3% | 50.3% | -65.6% | -100.6% |
| Dec 2024 | $10.42M | +80.7% | 68.9% | -596.4% | -553.7% |
| Dec 2023 | $5.77M | N/A | 66.5% | -32.5% | -64.6% |
| Dec 2022 | $0 | -100.0% | N/A | N/A | N/A |
| Dec 2021 | $7.34M | +7.8% | 80.7% | 3.4% | 6.5% |
| Dec 2020 | $6.80M | N/A | 80.3% | 5.9% | 3.8% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | $14.62M | $10.42M | $5.77M | $0 | $7.34M | $6.80M |
| Cost of revenue | $7.26M | $3.24M | $1.93M | $0 | $1.41M | $1.34M |
| Gross profit | $7.36M | $7.18M | $3.83M | $0 | $5.92M | $5.46M |
| Operating income | -$9.58M | -$62.15M | -$1.87M | -$3.59M | $252.28K | $404.50K |
| Net income | -$14.71M | -$57.70M | -$3.73M | -$3.24M | $475.90K | $258.88K |
| EBITDA | -$8.96M | -$57.10M | -$1.51M | N/A | $386.34K | $404.50K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56M | $3.16M | $3.93M | $3.98M | $1.06M | $3.32M | $3.73M | $3.35M | $1.71M | $1.62M | $3.02M | $1.45M |
| Gross profit | $206.15K | $1.20M | $1.83M | $2.07M | $615.04K | $1.86M | $2.38M | $2.78M | $777.00K | $1.23M | $2.04M | $973.07K |
| Operating income | -$2.70M | -$2.97M | -$3.44M | -$2.06M | -$1.56M | -$1.83M | -$3.03M | -$58.29M | -$932.52K | $104.06K | -$280.51K | -$274.36K |
| Net income | $847.27K | -$2.60M | -$7.85M | -$289.75K | -$2.61M | -$3.96M | -$3.21M | -$53.92M | -$666.10K | $94.75K | -$1.30M | -$98.58K |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $1.90M by $3.15M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Total assets | $22.41M | $19.99M | $805.79K | $7.63M | $117.94M | $2.73M |
| Current assets | $8.37M | $3.02M | $802.13K | $107.00K | $1.22M | $1.48M |
| Cash and equivalents | $5.05M | $326.12K | $118.73K | $107.00K | $760.01K | $775.24K |
| Total liabilities | $16.96M | $20.01M | $5.11M | $7.67M | $4.55M | $2.11M |
| Short-term debt | $1.31M | $7.85M | $923.00K | $0 | $0 | $133.08K |
| Long-term debt | $593.94K | $593.94K | $0 | N/A | N/A | N/A |
| Shareholder equity | $5.45M | -$18.49K | -$3.97M | -$7.43M | -$3.33M | $614.49K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.73M | $19.02M | $22.41M | $18.71M | $18.21M | $19.40M | $19.99M | $25.03M | $78.99M | $1.39M | $1.37M | $8.14M |
| Total liabilities | $9.14M | $12.70M | $16.96M | $24.28M | $23.95M | $22.89M | $20.01M | $20.27M | $24.18M | $13.34M | $12.35M | $9.39M |
| Cash and equivalents | $454.15K | $1.35M | $5.27M | $472.76K | $291.60K | $410.12K | $326.12K | $2.33M | $1.11M | $689.28K | $1.86K | $507 |
| Shareholder equity | $7.59M | $6.32M | $5.45M | -$5.58M | -$5.74M | -$3.50M | -$18.49K | $4.76M | $54.81M | -$13.23M | -$10.98M | -$9.15M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.45M | -$5.79M | -$632.60K | -$1.39M | -$600.11K | $789.12K |
| Capital expenditures | $29.93K | $55.27K | $4.33K | $3 | $3 | $0 |
| Free cash flow | -$3.48M | -$5.84M | -$636.93K | -$1.39M | -$600.12K | $789.12K |
| Dividends paid | $10.00K | $0 | $0 | N/A | N/A | N/A |
| Share repurchases | $44 | $5.15K | N/A | $110.47M | N/A | N/A |
| Investing cash flow | -$29.93K | -$26.14K | -$4.33K | $110.12M | -$116.73M | N/A |
| Financing cash flow | $8.42M | $6.02M | $525.00K | -$109.38M | $118.09M | -$83.67K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.17M | -$2.45M | -$1.93M | -$754.54K | -$324.60K | -$440.49K | -$2.97M | -$221.03K | -$3.17M | $579.29K | -$109.16K | -$48.79K |
| Capital expenditures | $73.25K | $26.75K | $7.15K | $7.31K | $11.87K | $11.87K | $4.76K | $4.99K | $36.77K | $8.74K | $1.65K | $3 |
| Free cash flow | -$1.25M | -$2.48M | -$1.93M | -$761.85K | -$336.47K | -$452.37K | -$2.98M | -$226.03K | -$3.21M | $570.55K | -$110.80K | -$48.80K |
Frequently Asked Questions About VSEE
What is VSee Health's annual revenue?
VSee Health reported revenue of $14.62M for the fiscal year ended Dec 31, 2025.
How fast is VSee Health's revenue growing?
Revenue was up 40.3% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is VSee Health profitable?
No. VSee Health reported net income of -$14.71M for the fiscal year ended Dec 31, 2025, with a net margin of -100.6%.
How much free cash flow does VSEE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$3.45M minus capital expenditures of $29.93K produced free cash flow of -$3.48M.
How much debt does VSee Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $593.94K, short-term debt of $1.31M and cash and equivalents of $5.05M.
VSEE pages: Overview, Financials, Competitors